Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AIM ImmunoTech Inc. (AIM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.5697-0.0003 (-0.05%)
At close: 03:59PM EDT
0.5800 +0.01 (+1.81%)
After hours: 05:58PM EDT
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    AIM ImmunoTech to Present at the Virtual Investor Long COVID Event

    Live video webcast with moderated roundtable between members of the AIM ImmunoTech Management Team and Key Opinion Leaders Dr. Charles Lapp of Hunter-Hopkins Center and Dr. Daniel Peterson of Sierra Internal Medicine on Wednesday, September 28th at 3:00 PM ETOCALA, Fla., Sept. 21, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune di

  • Business Wire

    AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders

    OCALA, Fla., September 19, 2022--The Board of Directors ("Board") of AIM ImmunoTech Inc. (NYSE: American AIM) ("AIM" or the "Company"), today announced that the Company has filed its Definitive Proxy Statement in connection with AIM’s upcoming 2022 Annual Meeting of Stockholders (the "Annual Meeting"), to be held on November 3, 2022, and has mailed this statement, along with a letter, to shareholders.

  • GlobeNewswire

    AIM ImmunoTech to Present at the H.C. Wainwright 24th Annual Global Investment Conference

    OCALA, Fla., Sept. 07, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus, today announced that Thomas K. Equels, M.S. J.D. Chief Executive Officer of AIM, will present at the virtual H.C. Wainwright 24th Annual Global Investment Conference

Advertisement
Advertisement